{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T05:17:00Z","timestamp":1738300620347,"version":"3.35.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00292-024-01402-w","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T16:21:39Z","timestamp":1734538899000},"page":"34-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathologie und Molekularpathologie des Peniskarzinoms","Pathology and molecular pathology of carcinoma of the penis"],"prefix":"10.1007","volume":"46","author":[{"given":"August","family":"Fiegl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Junker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Mink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Stoehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"1402_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray\u00a0F, Laversanne\u00a0M, Sung\u00a0H, Ferlay\u00a0J, Siegel\u00a0RL, Soerjomataram\u00a0I, Jemal\u00a0A (2024) Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"1402_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41585-021-00557-y","volume":"19","author":"M Bandini","year":"2022","unstructured":"Bandini\u00a0M, Ahmed\u00a0M, Basile\u00a0G, Watkin\u00a0N, Master\u00a0V, Zhu\u00a0Y, Prakash\u00a0G, Rodriguez\u00a0A, Ssebakumba\u00a0MK, Leni\u00a0R et\u00a0al (2022) A\u00a0global approach to improving penile cancer care. Nat Rev Urol 19:231\u2013239. https:\/\/doi.org\/10.1038\/s41585-021-00557-y","journal-title":"Nat Rev Urol"},{"key":"1402_CR3","doi-asserted-by":"publisher","first-page":"e34874","DOI":"10.2196\/34874","volume":"8","author":"L Fu","year":"2022","unstructured":"Fu\u00a0L, Tian\u00a0T, Yao\u00a0K, Chen\u00a0XF, Luo\u00a0G, Gao\u00a0Y, Lin\u00a0YF, Wang\u00a0B, Sun\u00a0Y, Zheng\u00a0W et\u00a0al (2022) Global pattern and trends in penile cancer incidence: Population-based study. Jmir Public Health Surveill 8:e34874. https:\/\/doi.org\/10.2196\/34874","journal-title":"Jmir Public Health Surveill"},{"key":"1402_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/s0022-5347(17)35221-7","volume":"151","author":"S Horenblas","year":"1994","unstructured":"Horenblas\u00a0S, van Tinteren\u00a0H (1994) Squamous cell carcinoma of the penis. Iv. Prognostic factors of survival: Analysis of tumor, nodes and metastasis classification system. J\u00a0Urol 151:1239\u20131243. https:\/\/doi.org\/10.1016\/s0022-5347(17)35221-7","journal-title":"J Urol"},{"key":"1402_CR5","doi-asserted-by":"publisher","first-page":"891623","DOI":"10.3389\/fonc.2022.891623","volume":"12","author":"X Deng","year":"2022","unstructured":"Deng\u00a0X, Liu\u00a0Y, Zhan\u00a0X, Chen\u00a0T, Jiang\u00a0M, Jiang\u00a0X, Chen\u00a0L, Fu\u00a0B (2022) Trends in incidence, mortality, and survival of penile cancer in the united states: A\u00a0population-based study. Front Oncol 12:891623. https:\/\/doi.org\/10.3389\/fonc.2022.891623","journal-title":"Front Oncol"},{"key":"1402_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15194748","author":"JN Mink","year":"2023","unstructured":"Mink\u00a0JN, Khalmurzaev\u00a0O, Pryalukhin\u00a0A, Geppert\u00a0CI, Lohse\u00a0S, Bende\u00a0K, Lobo\u00a0J, Henrique\u00a0R, Loertzer\u00a0H, Steffens\u00a0J et\u00a0al (2023) Evaluation of prognostic parameters to identify aggressive penile carcinomas. Cancers. https:\/\/doi.org\/10.3390\/cancers15194748","journal-title":"Cancers"},{"key":"1402_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00428-019-02607-8","volume":"475","author":"A Emmanuel","year":"2019","unstructured":"Emmanuel\u00a0A, Nettleton\u00a0J, Watkin\u00a0N, Berney\u00a0DM (2019) The molecular pathogenesis of penile carcinoma\u2014current developments and understanding. Virchows Arch 475:397\u2013405. https:\/\/doi.org\/10.1007\/s00428-019-02607-8 (https:\/\/doi.org\/10.1007\/s00428-019-02607-8)","journal-title":"Virchows Arch"},{"key":"1402_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00345-008-0302-z","volume":"27","author":"MC Bleeker","year":"2009","unstructured":"Bleeker\u00a0MC, Heideman\u00a0DA, Snijders\u00a0PJ, Horenblas\u00a0S, Dillner\u00a0J, Meijer\u00a0CJ (2009) Penile cancer: Epidemiology, pathogenesis and prevention. World J Urol 27:141\u2013150. https:\/\/doi.org\/10.1007\/s00345-008-0302-z","journal-title":"World J Urol"},{"key":"1402_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/380079a0","volume":"380","author":"AJ Klingelhutz","year":"1996","unstructured":"Klingelhutz\u00a0AJ, Foster\u00a0SA, McDougall\u00a0JK (1996) Telomerase activation by the e6 gene product of human papillomavirus type\u00a016. Nature 380:79\u201382. https:\/\/doi.org\/10.1038\/380079a0","journal-title":"Nature"},{"key":"1402_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.virol.2013.04.013","volume":"445","author":"A Roman","year":"2013","unstructured":"Roman\u00a0A, Munger\u00a0K (2013) The papillomavirus e7 proteins. Virology 445:138\u2013168. https:\/\/doi.org\/10.1016\/j.virol.2013.04.013","journal-title":"Virology"},{"key":"1402_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s1470-2045(18)30682-x","volume":"20","author":"TB Olesen","year":"2019","unstructured":"Olesen\u00a0TB, Sand\u00a0FL, Rasmussen\u00a0CL, Albieri\u00a0V, Toft\u00a0BG, Norrild\u00a0B, Munk\u00a0C, Kj\u00e6r\u00a0SK (2019) Prevalence of human papillomavirus DNA and p16(ink4a) in penile cancer and penile intraepithelial neoplasia: A\u00a0systematic review and meta-analysis. Lancet Oncol 20:145\u2013158. https:\/\/doi.org\/10.1016\/s1470-2045(18)30682-x","journal-title":"Lancet Oncol"},{"key":"1402_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/jdv.18663","volume":"37","author":"T Ju","year":"2023","unstructured":"Ju\u00a0T, Hernandez\u00a0L, Mohsin\u00a0N, Labib\u00a0A, Frech\u00a0F, Nouri\u00a0K (2023) Evaluation of risk in chronic cutaneous inflammatory conditions for malignant transformation. J\u00a0Eur Acad Dermatol Venereol 37:231\u2013242. https:\/\/doi.org\/10.1111\/jdv.18663","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1402_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.eururo.2024.03.038","volume":"86","author":"L Elst","year":"2024","unstructured":"Elst\u00a0L, Philips\u00a0G, Vandermaesen\u00a0K, Bassez\u00a0A, Lodi\u00a0F, Vreeburg\u00a0MTA, Brouwer\u00a0OR, Schepers\u00a0R, Van Brussel\u00a0T, Mohanty\u00a0SK et\u00a0al (2024) Single-cell atlas of penile cancer reveals tp53 mutations as a\u00a0driver of an aggressive phenotype, irrespective of human papillomavirus status, and provides clues for treatment personalization. Eur Urol 86:114\u2013127. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.038","journal-title":"Eur Urol"},{"key":"1402_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00428-010-1007-4","volume":"458","author":"M oetsch","year":"2011","unstructured":"oetsch\u00a0M, Hemmerich\u00a0M, Kakies\u00a0C, Kleist\u00a0B, Wolf\u00a0E, vom Dorp\u00a0F, Hakenberg\u00a0OW, Protzel\u00a0C (2011) Alterations in the tumor suppressor gene p16(ink4a) are associated with aggressive behavior of penile carcinomas. Virchows Arch 458:221\u2013229. https:\/\/doi.org\/10.1007\/s00428-010-1007-4","journal-title":"Virchows Arch"},{"key":"1402_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1055\/a-2104-1270","volume":"54","author":"JN Mink","year":"2023","unstructured":"Mink\u00a0JN, Khalmurzaev\u00a0O, Pryalukhin\u00a0A, H\u00f6lters\u00a0S, Geppert\u00a0C, Lohse\u00a0S, Bende\u00a0K, Lobo\u00a0J, Henrique\u00a0R, Loertzer\u00a0H et\u00a0al (2023) importance of hpv status and p16 for the prognosis of penile carcinoma. Aktuelle Urol 54:274\u2013284. https:\/\/doi.org\/10.1055\/a-2104-1270","journal-title":"Aktuelle Urol"},{"key":"1402_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaad.2012.12.973","volume":"69","author":"S Mannweiler","year":"2013","unstructured":"Mannweiler\u00a0S, Sygulla\u00a0S, Winter\u00a0E, Regauer\u00a0S (2013) Two major pathways of penile carcinogenesis: Hpv-induced penile cancers overexpress p16ink4a, hpv-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression. J\u00a0Am Acad Dermatol 69:73\u201381. https:\/\/doi.org\/10.1016\/j.jaad.2012.12.973","journal-title":"J Am Acad Dermatol"},{"key":"1402_CR17","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1002\/cncr.34982","volume":"129","author":"B Nazha","year":"2023","unstructured":"Nazha\u00a0B, Zhuang\u00a0T, Wu\u00a0S, Brown\u00a0JT, Magee\u00a0D, Carthon\u00a0BC, Kucuk\u00a0O, Nabhan\u00a0C, Barata\u00a0PC, Heath\u00a0EI et\u00a0al (2023) Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers. Cancer 129:3884\u20133893. https:\/\/doi.org\/10.1002\/cncr.34982","journal-title":"Cancer"},{"key":"1402_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000495251","volume":"86","author":"R Stoehr","year":"2019","unstructured":"Stoehr\u00a0R, Wendler\u00a0O, Giedl\u00a0J, Gaisa\u00a0NT, Richter\u00a0G, Campean\u00a0V, Burger\u00a0M, Wullich\u00a0B, Bertz\u00a0S, Hartmann\u00a0A (2019) No evidence of microsatellite instability and loss of mismatch-repair-protein expression in squamous cell carcinoma of the penis. Pathobiology 86:145\u2013151. https:\/\/doi.org\/10.1159\/000495251","journal-title":"Pathobiology"},{"issue":"1706-12","key":"1402_CR19","doi-asserted-by":"publisher","first-page":"092375341935862","DOI":"10.1093\/annonc\/mdw216","volume":"27","author":"AM Udager","year":"2016","unstructured":"Udager\u00a0AM, Liu\u00a0TY, Skala\u00a0SL, Magers\u00a0MJ, McDaniel\u00a0AS, Spratt\u00a0DE, Feng\u00a0FY, Siddiqui\u00a0J, Cao\u00a0X, Fields\u00a0KL et\u00a0al (2016) Frequent pd-l1 expression in primary and metastatic penile squamous cell carcinoma: Potential opportunities for immunotherapeutic approaches. Ann Oncol 27(1706-12):923753419358624. https:\/\/doi.org\/10.1093\/annonc\/mdw216","journal-title":"Ann Oncol"},{"key":"1402_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.humpath.2023.10.003","volume":"142","author":"B Tekin","year":"2023","unstructured":"Tekin\u00a0B, Cheville\u00a0JC, Herrera Hernandez\u00a0L, Negron\u00a0V, Smith\u00a0CY, Jenkins\u00a0SM, Dasari\u00a0S, Enninga\u00a0EAL, Norgan\u00a0AP, Menon\u00a0S et\u00a0al (2023) Assessment of pd-l1, trop2, and nectin\u20114 expression in penile squamous cell carcinoma. Hum Pathol 142:42\u201350. https:\/\/doi.org\/10.1016\/j.humpath.2023.10.003","journal-title":"Hum Pathol"},{"key":"1402_CR21","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1200\/jco.22.02894","volume":"41","author":"HM de Vries","year":"2023","unstructured":"de Vries\u00a0HM, Rafael\u00a0TS, Gil-Jimenez\u00a0A, de Feijter\u00a0JM, Bekers\u00a0E, van der Laan\u00a0E, Lopez-Yurda\u00a0M, Hooijberg\u00a0E, Broeks\u00a0A, Peters\u00a0D et\u00a0al (2023) Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis (the pericles study): A\u00a0phase ii trial. J\u00a0Clin Oncol 41:4872\u20134880. https:\/\/doi.org\/10.1200\/jco.22.02894","journal-title":"J Clin Oncol"},{"key":"1402_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euros.2022.12.008","volume":"49","author":"GD Grass","year":"2023","unstructured":"Grass\u00a0GD, Chahoud\u00a0J, Lopez\u00a0A, Dhillon\u00a0J, Eschrich\u00a0SA, Johnstone\u00a0PAS, Spiess\u00a0PE (2023) An analysis of nectin\u20114 (pvrl4) in penile squamous cell carcinoma. Eur Urol Open Sci 49:1\u20135. https:\/\/doi.org\/10.1016\/j.euros.2022.12.008","journal-title":"Eur Urol Open Sci"},{"key":"1402_CR23","unstructured":"ClinicalTrials.gov. Clinicaltrials.Gov. https:\/\/clinicaltrials.gov\/study\/NCT06104618?cond=Penile%20Cancer&intr=Enfortumab%20vedotin&rank=1"},{"key":"1402_CR24","unstructured":"Clinicaltrials.Gov. https:\/\/clinicaltrials.gov\/study\/NCT06161532?cond=Penile%20Cancer&intr=Sacituzumab%20govitecan&rank=1"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-024-01402-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-024-01402-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-024-01402-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T16:41:32Z","timestamp":1738255292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-024-01402-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1007\/s00292-024-01402-w","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"type":"print","value":"2731-7188"},{"type":"electronic","value":"2731-7196"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"19 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Fiegl, K.\u00a0Junker, J.\u00a0Mink und R.\u00a0Stoehr geben an, dass kein Interessenkonflikt besteht. A.\u00a0Hartmann erh\u00e4lt Honorare von Abbvie, AstraZeneca, Biontech, BMS, Boehringer Ingelheim, Cepheid, Diaceutics, Ipsen, Janssen, Lilly, MSD, Nanostring, Novartis, Roche, 3DHISTECH; Beratungsgeb\u00fchren von Abbvie, AstraZeneca, Biontech, BMS, Boehringer Ingelheim, Cepheid, Diaceutics, Gilead, Illumina, Ipsen, Janssen, Lilly, MSD, Nanostring, Novartis, Qiagen, QUIP GmbH, Roche, 3DHISTECH; Forschungsf\u00f6rderung von AstraZeneca, Biontech, Cepheid, Gilead, Illumina, Janssen, Nanostring, Qiagen, QUIP GmbH, Roche.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}